Renal thrombotic microangiopathy in mice with combined deletion of endocytic recycling regulators EHD3 and EHD4

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  George, Manju ^a   Rainey, Mark A ^b   Naramura, Mayumi ^a   Foster, Kirk W ^c   Holzapfel, Melissa S ^c   Willoughby, Laura L ^a   Ying, GuoGuang ^d   Goswami, Rasna M ^e   Gurumurthy, Channabasavaiah B ^c   Band, Vimla ^a,c   Satchell, Simon C ^f   Band, Hamid ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e ABBOTT LABORATORIES   (United States)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPS15 HOMOLOGY DOMAIN CONTAINING PROTEIN 3; EPS15 HOMOLOGY DOMAIN CONTAINING PROTEIN 4; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER; CARRIER PROTEIN; DNA BINDING PROTEIN; EHD3 PROTEIN, MOUSE; EHD4 PROTEIN, MOUSE; NUCLEAR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM INJURY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE INACTIVATION; KIDNEY DEVELOPMENT; KNOCKOUT MOUSE; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PHENOTYPE; PODOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; UPREGULATION; ANIMAL; ENDOTHELIUM; HUMAN; KIDNEY; MESANGIUM; METABOLISM; PATHOLOGY; STAINING; ULTRASTRUCTURE;

ANIMALIA; MUS;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CARRIER PROTEINS; DNA-BINDING PROTEINS; ENDOCYTOSIS; ENDOTHELIUM; GENE DELETION; GLOMERULAR MESANGIUM; HUMANS; KIDNEY; MICE; NUCLEAR PROTEINS; PODOCYTES; PROTEINURIA; STAINING AND LABELING; THROMBOTIC MICROANGIOPATHIES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79952398627     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017838     Document Type: Article

References (43)

1. Ballermann BJ, (2007) Contribution of the endothelium to the glomerular permselectivity barrier in health and disease. Nephron Physiol 106: p19-25.
2. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, et al. (1997) Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258.
3. Abrahamson DR, (2009) Development of kidney glomerular endothelial cells and their role in basement membrane assembly. Organogenesis 5: 275-287.
4. Haraldsson B, Nystrom J, Deen WM, (2008) Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 88: 451-487.
5. Patrakka J, Tryggvason K, (2010) Molecular make-up of the glomerular filtration barrier. Biochem Biophys Res Commun 396: 164-169.
6. Jarad G, Miner JH, (2009) Update on the glomerular filtration barrier. Curr Opin Nephrol Hypertens 18: 226-232.
7. Kerjaschki D, (2001) Caught flat-footed: Podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 108: 1583-1587.
8. Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K, (2001) The murine nephrin gene is specifically expressed in kidney, brain and pancreas: Inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10: 1-8.
9. Donoviel DB, Freed DD, Vogel H, Potter DG, Hawkins E, et al. (2001) Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 21: 4829-4836.
10. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, et al. (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24: 349-354.
11. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, et al. (1998) Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582.
12. Huber TB, Hartleben B, Winkelmann K, Schneider L, Becker JU, et al. (2009) Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol 20: 798-806.
13. Takeda T, McQuistan T, Orlando RA, Farquhar MG, (2001) Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 108: 289-301.
14. Patrakka J, Tryggvason K, (2009) New insights into the role of podocytes in proteinuria. Nat Rev Nephrol 5: 463-468.
15. Grant BD, Caplan S, (2008) Mechanisms of EHD/RME-1 protein function in endocytic transport. Traffic.
16. Patrakka J, Xiao Z, Nukui M, Takemoto M, He L, et al. (2007) Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066E14Rik. J Am Soc Nephrol 18: 689-697.
17. Brunskill EW, Potter SS, (2010) Gene expression programs of mouse endothelial cells in kidney development and disease. PLoS One 5: e12034.
18. Guilherme A, Soriano NA, Furcinitti PS, Czech MP, (2004) Role of EHD1 and EHBP1 in perinuclear sorting and insulin-regulated GLUT4 recycling in 3T3-L1 adipocytes. J Biol Chem 279: 40062-40075.
19. Gudmundsson H, Hund TJ, Wright PJ, Kline CF, Snyder JS, et al. (2010) EH domain proteins regulate cardiac membrane protein targeting. Circ Res.
20. Doherty KR, Demonbreun AR, Wallace GQ, Cave A, Posey AD, et al. (2008) The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion. J Biol Chem 283: 20252-20260.
21. Jia J, Wang J, Teh M, Sun W, Zhang J, et al. (2010) Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE. Proteomics 10: 224-234.
22. Yap CC, Lasiecka ZM, Caplan S, Winckler B, (2010) Alterations of EHD1/EHD4 protein levels interfere with L1/NgCAM endocytosis in neurons and disrupt axonal targeting. J Neurosci 30: 6646-6657.
23. Naslavsky N, Rahajeng J, Chenavas S, Sorgen PL, Caplan S, (2007) EHD1 and Eps15 interact with phosphatidylinositols via their Eps15 homology domains. J Biol Chem 282: 16612-16622.
24. Blume JJ, Halbach A, Behrendt D, Paulsson M, Plomann M, (2007) EHD proteins are associated with tubular and vesicular compartments and interact with specific phospholipids. Exp Cell Res 313: 219-231.
25. Lee DW, Zhao X, Scarselletta S, Schweinsberg PJ, Eisenberg E, et al. (2005) ATP binding regulates oligomerization and endosome association of RME-1 family proteins. J Biol Chem 280: 17213-17220.
26. Naslavsky N, Rahajeng J, Sharma M, Jovic M, Caplan S, (2006) Interactions between EHD proteins and Rab11-FIP2: A role for EHD3 in early endosomal transport. Mol Biol Cell 17: 163-177.
27. Rainey MA, George M, Ying G, Akakura R, Burgess DJ, et al. (2010) The endocytic recycling regulator EHD1 is essential for spermatogenesis and male fertility in mice. BMC Dev Biol 10: 37.
28. George M, Rainey MA, Naramura M, Ying G, Harms DW, et al. (2010) Ehd4 is required to attain normal prepubertal testis size but dispensable for fertility in male mice. Genesis 48: 328-342.
29. Porter GA, Palade GE, Milici AJ, (1990) Differential binding of the lectins Griffonia simplicifolia I and Lycopersicon esculentum to microvascular endothelium: organ-specific localization and partial glycoprotein characterization. Eur J Cell Biol 51: 85-95.
30. Quaggin SE, Kreidberg JA, (2008) Development of the renal glomerulus: Good neighbors and good fences. Development 135: 609-620.
31. Sengupta S, George M, Miller KK, Naik K, Chou J, et al. (2009) EHD4 and CDH23 are interacting partners in cochlear hair cells. J Biol Chem 284: 20121-20129.
32. Stillman IE, Karumanchi SA, (2007) The glomerular injury of preeclampsia. J Am Soc Nephrol 18: 2281-2284.
33. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, et al. (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129-1136.
34. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, et al. (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716.
35. Eremina V, Baelde HJ, Quaggin SE, (2007) Role of the VEGF-a signaling pathway in the glomerulus: Evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 106: p32-7.
36. Foster RR, (2009) The importance of cellular VEGF bioactivity in the development of glomerular disease. Nephron Exp Nephrol 113: e8-e15.
37. Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, et al. (2006) Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 17: 724-735.
38. Sano H, Ueda Y, Takakura N, Takemura G, Doi T, et al. (2002) Blockade of platelet-derived growth factor receptor-beta pathway induces apoptosis of vascular endothelial cells and disrupts glomerular capillary formation in neonatal mice. Am J Pathol 161: 135-143.
39. Lindahl P, Hellstrom M, Kalen M, Karlsson L, Pekny M, et al. (1998) Paracrine PDGF-B/PDGF-rbeta signaling controls mesangial cell development in kidney glomeruli. Development 125: 3313-3322.
40. Sison K, Eremina V, Baelde H, Min W, Hirashima M, et al. (2010) Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J Am Soc Nephrol 21: 1691-1701.
41. Scott A, Mellor H, (2009) VEGF receptor trafficking in angiogenesis. Biochem Soc Trans 37: 1184-1188.
42. Gampel A, Moss L, Jones MC, Brunton V, Norman JC, et al. (2006) VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment. Blood 108: 2624-2631.
43. George M, Ying G, Rainey MA, Solomon A, Parikh PT, et al. (2007) Shared as well as distinct roles of EHD proteins revealed by biochemical and functional comparisons in mammalian cells and C. elegans. BMC Cell Biol 8: 3.